top of page
Biotech Stories, News & Events

Team AlgaLab is the winner of the fifth BioFinland Pitching Competition

  • Oct 2, 2023
  • 1 min read

The AlgaLab team, comprised of Saana Soppela, Minne Jartti, and Stina Gröhn from Tampere University, won the fifth BioFinland pitching competition held on September 29th at Pörssitalo, Helsinki.


BioFinland Pitching Competition


The competition's aim is to inspire students to adopt a positive stance towards biobusiness and entrepreneurship. Finnish Bioindustries FIB organized the competition in collaboration with HiLife and Nasdaq Helsinki as part of the European Biotech Week.

Finnish Bioindustries invited all students at Finnish universities and universities of applied sciences, including bachelor, master, doctoral, and graduate school students, to participate in the competition. Out of all the entrants, four teams were selected to compete in the final. The pitched ideas ranged from Parkinson’s disease treatment to health data solutions. The winning pitch involved using algae for protein production in vaccine manufacturing.


The pitches were of excellent quality, and the jury was tasked with a challenging decision. The jury members for this edition included Maarit Merla from Organon R&D Finland and Chair of Finnish Bioindustries, Pekka Simula from Innovestor Life Science, Minna Korpi from Nasdaq Helsinki, Vincenzo Cerullo and Johan Lundin, both from HiLIFE.


The competition prize is €1000, and the winner also gets a picture to the Nasdaq MarketSite in New York City's Times Square.

Microscopic view of blue-grey yeast cells

Similar Stories from FIB

Member Profile: TILT Biotherapeutics – Developer of a Virus-Based Cancer Therapy

21/01/26

Member Profile: TILT Biotherapeutics – Developer of a Virus-Based Cancer Therapy

Finns Fighting Cancer – A Small Nation with Global Impact

18/12/25

Finns Fighting Cancer – A Small Nation with Global Impact

Member Spotlight: Herantis Pharma – aiming to stop the progression of Parkinson’s disease

10/11/25

Member Spotlight: Herantis Pharma – aiming to stop the progression of Parkinson’s disease

HAMK invests in biotechnology

29/10/25

HAMK invests in biotechnology

bottom of page